LINC00210

Across TCGA pan-cancer cohorts, LINC00210 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC00210 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC00210 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00210 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

MESO, KICH, and KIRC are the cancer types where LINC00210 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
KIRC	DFS	Tertile	II,III,IV	0.217	0.760	.010	54	view →
HNSC	DFS	Tertile	II,III,IV	0.716	0.312	.014	33	view →
SARC	DFS	Tertile	All	0.173	0.602	.001	27	view →
ESCA	OS	Tertile	III,IV	0.769	0.362	.018	18	view →
PCPG	OS	Tertile	All	0.571	0.963	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.157	0.696	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC00210–MESO (OS)

Open the MESO breakdown →